Why are so many drug discoveries still failing to make it out of the lab when the speed of, and competition for, innovation has never been higher? Could solving this challenge lie in the unique relationship between academia and industry that is currently being overlooked? In this session, experts from global pharma, biotech and academia will discuss how evolving collaboration models are bridging the innovation “valley of death” – the gap between research and patient care. Attendees will learn how industry and academia can be the very best partners to one another, what good looks like for building long-term collaborations, and what’s needed to ensure more scientific breakthroughs reach patients, faster.